ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising enhancements across a variety of medical and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, more responsible alternate for therapeutic use, specially